Literature DB >> 3440332

Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura.

C Montecucco1, M Di Lauro, E Bobbio-Pallavicini, M Longhi, R Caporali, F De Gennaro, E Ascari.   

Abstract

Anti-phospholipid antibodies were measured in 9 patients with active thrombotic thrombocytopenic purpura (TTP). 8 patients had primary TTP and one had TTP secondary to systemic lupus erythematosus (SLE). No patient showed circulating 'lupus' anticoagulants or false positive tests for syphilis. A solid phase immuno-assay for anti-cardiolipin antibodies (ACA) gave negative results in the patient with secondary TTP as well as in all but one case with primary TTP. ACA of IgG class were not found in any TTP patient while they were present in 10 out of 18 patients suffering from thrombocytopenia with active SLE. These data indicate that anti-phospholipid antibodies do not have a role in the development of thrombosis and thrombocytopenia with TTP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440332

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Clinical, genetic and immunologic analysis of a family affected by ozena.

Authors:  Lucia Medina; Marco Benazzo; Giulia Bertino; Carlo Maurizio Montecucco; Cesare Danesino; Miryam Martinetti; Eugenio Mira
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-26       Impact factor: 2.503

Review 2.  Treatment of catastrophic antiphospholipid syndrome.

Authors:  Nayef M Kazzaz; W Joseph McCune; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

3.  A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia.

Authors:  Nayef M Kazzaz; Allecia M Wilson; Ruba Kado; Geoffrey D Barnes; Jason S Knight
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08       Impact factor: 4.794

Review 4.  Catastrophic APS in the context of other thrombotic microangiopathies.

Authors:  Ignasi Rodríguez-Pintó; Gerard Espinosa; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

5.  Prevalence of anticardiolipin antibodies in juvenile chronic arthritis.

Authors:  R Caporali; A Ravelli; F De Gennaro; G Neirotti; C Montecucco; A Martini
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

Review 6.  Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.

Authors:  G Espinosa; S Bucciarelli; R Cervera; M Lozano; J-C Reverter; G de la Red; V Gil; M Ingelmo; J Font; R A Asherson
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

7.  Anticardiolipin antibodies in children and adolescents with insulin-dependent diabetes mellitus.

Authors:  R Lorini; G d'Annunzio; C Montecucco; R Caporali; L Vitali; P Pessino; F Severi
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.